217 related articles for article (PubMed ID: 33423645)
1. Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators.
Rauscher S; Greil R; Geisberger R
Curr Cancer Drug Targets; 2021; 21(4):353-359. PubMed ID: 33423645
[TBL] [Abstract][Full Text] [Related]
2. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
[TBL] [Abstract][Full Text] [Related]
3. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
[TBL] [Abstract][Full Text] [Related]
4. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
Li Y; Li Z; Zhu WG
Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
8. Cancer's epigenetic drugs: where are they in the cancer medicines?
Ghasemi S
Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
10. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
Strauss J; Figg WD
Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for epigenetic therapy of cancer.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Curr Pharm Biotechnol; 2009 Feb; 10(2):161-5. PubMed ID: 19199948
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Therapies and Potential Drugs for Treating Human Cancer.
Lin SQ; Li X
Curr Drug Targets; 2020; 21(11):1068-1083. PubMed ID: 32209040
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic targeting therapies to overcome chemotherapy resistance.
Balch C; Nephew KP
Adv Exp Med Biol; 2013; 754():285-311. PubMed ID: 22956507
[TBL] [Abstract][Full Text] [Related]
14. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Perez-Plasencia C; Duenas-Gonzalez A
Mol Cancer; 2006 Jul; 5():27. PubMed ID: 16831224
[TBL] [Abstract][Full Text] [Related]
15. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
Guo L; Lee YT; Zhou Y; Huang Y
Semin Cancer Biol; 2022 Aug; 83():487-502. PubMed ID: 33421619
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
17. The bitter side of epigenetics: variability and resistance to chemotherapy.
Hajji N; García-Domínguez DJ; Hontecillas-Prieto L; O'Neill K; de Álava E; Syed N
Epigenomics; 2021 Mar; 13(5):397-403. PubMed ID: 29932342
[TBL] [Abstract][Full Text] [Related]
18. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms.
Mora Y; Reyes ME; Zanella L; Mora B; Buchegger K; Ili C; Brebi P
Pharmacogenomics; 2021 Aug; 22(12):777-790. PubMed ID: 34281355
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment.
Gyparaki MT; Papavassiliou AG
Clin Breast Cancer; 2018 Jun; 18(3):189-191. PubMed ID: 29042129
[No Abstract] [Full Text] [Related]
20. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
Rastgoo N; Abdi J; Hou J; Chang H
J Hematol Oncol; 2017 Jun; 10(1):121. PubMed ID: 28623912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]